Natco Pharma Limited
NATCOPHARM

Natco Pharma Limited

Pharmaceuticals
Share price
₹814
Market cap
₹16,027 Cr
1Y return
▼ 6%

A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.

Investors holding Natco Pharma Limited

B
Belgrave
Foreign Investor
2.31%
LIC
LIC
Institution
2.24%
Tata Mutual Fund
Tata Mutual Fund
Mutual Fund
1.03%
1.01%

Recent moves 15

Moves15
11moves in the last 30 days
Members only

Including 2 new positions

Unlock all 11 moves
Tata Mutual FundNew position
Tata Mutual Fund raised its stake in Natco Pharma to 1.03%, up from under 1% in the prior period, now holding 18,38,744 shares.
16 Oct 2026
Read more
Durga Devi NannapaneniDecreased
Promoter Durga Devi Nannapaneni sold 50,000 shares of Natco Pharma in an off-market transaction, decreasing her stake from 1.98% to 1.95%.
24 Aug 2026
Read more
LICNew position
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake.
10 Jul 2026
Read more
SANJAY NANNAPANENI and SATYA VANI NANNAPANENIDecreased
Sanjay Nannapaneni and Satya Vani Nannapaneni sold 1.15 lakh shares of Natco Pharma for ₹11.63 Cr at ₹1017.31 apiece, reducing the promoter group's stake from 0.13% to 0.09%.
9 Mar 2026
Read more

Track the whales in Natco Pharma Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1